<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01520597</url>
  </required_header>
  <id_info>
    <org_study_id>AOM 09068</org_study_id>
    <nct_id>NCT01520597</nct_id>
  </id_info>
  <brief_title>National Study on Listeriosis and Listeria</brief_title>
  <acronym>MONALISA</acronym>
  <official_title>Multicentric Observational NAtional Study on LISteriosis and ListeriA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut Pasteur</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>French National sanitory</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Listeriosis is a foodborne infection responsible for severe disease. Three main forms are&#xD;
      described: septicaemia, central nervous system infections and maternal-fetal infections.&#xD;
      Available data on the disease, are mostly retrospective and do not provide an accurate&#xD;
      picture of the clinical / biological / genetic risk factors for the disease, nor identify any&#xD;
      element to determine which patients are at higher risk of death, severe neurological&#xD;
      impairment or fetal loss.&#xD;
&#xD;
      The primary purpose of the study is to identify clinical, biological and genetic risk factors&#xD;
      for systemic listeriosis and the determinants of listeriosis-associated mortality in the&#xD;
      setting of a large prospective nation-wide study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Context: Listeriosis is a foodborne infection responsible for severe disease. Surveillance of&#xD;
      human listeriosis in France is based on both mandatory reporting of cases and voluntary&#xD;
      submission of L. monocytogenes strains to the National Reference Center for Listeria (NRC)&#xD;
      since 1999. The exhaustiveness of this reporting estimated by capture-recapture is of at&#xD;
      least 87%. A recent and consistent increase of sporadic and cluster-associated systemic&#xD;
      listeriosis cases has been reported in Europe since several years (since 2006 in France), but&#xD;
      remains poorly understood in the absence of any new environmental risk factor(s). A total of&#xD;
      322 cases have been reported in 2009 in France. Three main clinical forms are identified:&#xD;
      septicemia, central nervous system and maternal-fetal infection. They have been characterized&#xD;
      only through retrospective studies and pooling of heterogeneous patients. Such studies do not&#xD;
      provide an accurate picture of the disease and fail to identify precise biological / genetic&#xD;
      risk factors for the disease. Prognostic factors associated with higher risk of death, of&#xD;
      severe neurological impairment or of fetal loss also remain to be determined.&#xD;
&#xD;
      Main purpose:&#xD;
&#xD;
      - to study clinical, biological and genetic risk factors for systemic listeriosis and&#xD;
      identify determinants of listeriosis-associated mortality in the setting of a large&#xD;
      prospective nation-wide study&#xD;
&#xD;
      Secondary purposes:&#xD;
&#xD;
        -  to determine the clinical/biological and radiological presentation of listeriosis&#xD;
&#xD;
        -  to describe and further study current therapeutic practices in the 3 forms of the&#xD;
           disease (namely, septicaemic, neurologic and maternal-fetal)&#xD;
&#xD;
        -  to identify inherited risk factors for listeriosis&#xD;
&#xD;
      Ancillary studies:&#xD;
&#xD;
      - to evaluate serologic/PCR diagnostic tools&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      National prospective multicenter study with nested case control study. Clinical, biological&#xD;
      and radiological data are collected. Additionally a questionnaire focusing on dietary habits&#xD;
      is proposed. A bank of biological samples is performed. For each patient, 25ml of heparinized&#xD;
      blood / and 2ml of serum are collected per patient&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2009</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical, biological and genetic risk factors for systemic listeriosis</measure>
    <time_frame>At Day 1 (case and control)</time_frame>
    <description>Clinical, biological and genetic risk factors for systemic listeriosis and identify determinants of listeriosis-associated mortality in the setting of a large prospective nation-wide study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical, biological and genetic risk factors for systemic listeriosis</measure>
    <time_frame>At Day 90 (case)</time_frame>
    <description>Clinical, biological and genetic risk factors for systemic listeriosis and identify determinants of listeriosis-associated mortality in the setting of a large prospective nation-wide study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical/biological and radiological presentation of listeriosis</measure>
    <time_frame>At Day 1 and Day 90 (case), at Day 1 (control)</time_frame>
    <description>To determine the clinical/biological and radiological presentation of listeriosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current therapeutic practices</measure>
    <time_frame>At Day 1 and Day 90 (case), at Day 1 (control)</time_frame>
    <description>to describe and further study current therapeutic practices in the 3 forms of the disease (septicaemic, neurological and maternal-fetal)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Listeriosis</condition>
  <condition>Pregnancy Complications</condition>
  <condition>Infectious</condition>
  <condition>Central Nervous System Infections</condition>
  <condition>Septicemia</condition>
  <condition>Sepsis; Listeria Monocytogenes</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <description>Patient with culture-proven listeriosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patient above the age of 18 years with medical background and clinical features compatible with one of the 3 forms of systemic listeriosis: febrile pregnant women (temp &gt; 38°C), febrile patient with co-morbidity for septicaemic listeriosis, and any febrile symptom leading to empiric amoxicillin prescription.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Case: patient with culture-proven listeriosis (blood CSF, fetal/placental sample, other…).&#xD;
&#xD;
        Controls: patient above the age of 18 years with medical background and clinical features&#xD;
        compatible with one of the 3 forms of systemic listeriosis: febrile pregnant women (temp &gt;&#xD;
        38°C), febrile patient with co-morbidity for septicaemic listeriosis, and any febrile&#xD;
        symptom leading to empiric amoxicillin prescription.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Case:&#xD;
&#xD;
          -  Patient with culture-proven listeriosis (blood, CSF, fetal/placental sample, other…).&#xD;
&#xD;
        Control:&#xD;
&#xD;
          -  Patient above the age of 18 years with medical background and clinical features&#xD;
             compatible with one of the 3 forms of systemic listeriosis: febrile pregnant women&#xD;
             (temp &gt; 38°C), febrile patient with co-morbidity for septicaemic listeriosis, and any&#xD;
             febrile symptom leading to empiric amoxicillin prescription.&#xD;
&#xD;
          -  For feasibility reasons, controls are included in Paris (France) emergency wards.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Case:&#xD;
&#xD;
          -  Patient who would refuse to sign informed consent agreement&#xD;
&#xD;
        Control:&#xD;
&#xD;
          -  Patient who would refuse to sign informed consent agreement, or whose samples would&#xD;
             evidence L. monocytogenes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caroline Charlier, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Pasteur</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lecuit Marc, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institut Pasteur</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caroline Charlier, MD, PhD</last_name>
    <phone>+33(0) 1 42 19 26 63</phone>
    <email>caroline.charlier@nck.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurence Lecomte, PhD</last_name>
    <phone>+33 (0)1 71 19 64 94</phone>
    <email>laurence.lecomte@nck.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre National de Reference et Centre Collaborateur OMS Listeria, Institut Pasteur</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Charlier, MD PhD</last_name>
      <phone>+33 (0)1 42 19 26 63</phone>
      <email>caroline.charlier@nck.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore). 1998 Sep;77(5):313-36. Review.</citation>
    <PMID>9772921</PMID>
  </reference>
  <reference>
    <citation>Mylonakis E, Paliou M, Hohmann EL, Calderwood SB, Wing EJ. Listeriosis during pregnancy: a case series and review of 222 cases. Medicine (Baltimore). 2002 Jul;81(4):260-9. Review.</citation>
    <PMID>12169881</PMID>
  </reference>
  <reference>
    <citation>Lecuit M, Vandormael-Pournin S, Lefort J, Huerre M, Gounon P, Dupuy C, Babinet C, Cossart P. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science. 2001 Jun 1;292(5522):1722-5.</citation>
    <PMID>11387478</PMID>
  </reference>
  <reference>
    <citation>Disson O, Grayo S, Huillet E, Nikitas G, Langa-Vives F, Dussurget O, Ragon M, Le Monnier A, Babinet C, Cossart P, Lecuit M. Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature. 2008 Oct 23;455(7216):1114-8. doi: 10.1038/nature07303. Epub 2008 Sep 17.</citation>
    <PMID>18806773</PMID>
  </reference>
  <reference>
    <citation>Charlier C, Leclercq A, Cazenave B, Desplaces N, Travier L, Cantinelli T, Lortholary O, Goulet V, Le Monnier A, Lecuit M; L monocytogenes Joint and Bone Infections Study Group. Listeria monocytogenes-associated joint and bone infections: a study of 43 consecutive cases. Clin Infect Dis. 2012 Jan 15;54(2):240-8. doi: 10.1093/cid/cir803. Epub 2011 Nov 18.</citation>
    <PMID>22100574</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 3, 2012</study_first_submitted>
  <study_first_submitted_qc>January 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2012</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Multicentric</keyword>
  <keyword>National</keyword>
  <keyword>Prospective on</keyword>
  <keyword>Listeriosis</keyword>
  <keyword>Listeria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Central Nervous System Infections</mesh_term>
    <mesh_term>Listeriosis</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

